Nc. Munshi et al., THYMIDINE KINASE (TK) GENE-TRANSDUCED HUMAN-LYMPHOCYTES CAN BE HIGHLYPURIFIED, REMAIN FULLY FUNCTIONAL, AND ARE KILLED EFFICIENTLY WITH GANCICLOVIR, Blood, 89(4), 1997, pp. 1334-1340
A graft-versus-leukemia (GVL) effect has been considered a major facto
r responsible for cures in patients with hematologic malignancies unde
rgoing allogeneic bone marrow transplantation; however, associated gra
ft-versus-host disease (GVHD) results in significant morbidity and mor
tality. T-cell depletion reduces the incidence and severity of GVHD bu
t eliminates, at least partially, the GVL effect. Reinfusion of donor
T lymphocytes at relapse posttransplantation can induce a potent antit
umor response, but GVHD still occurs in the majority of patients. Prio
r transduction of T lymphocytes with the suicide gene, the viral thymi
dine kinase (TK), permits specific cell kill on administration of ganc
iclovir (GCV). Therefore, infusion of TK-transduced T lymphocytes may
induce GVL effect and allow for their subsequent selective elimination
in case GVHD develops. To evaluate the efficacy and feasibility of th
is promising approach, anti-CD3-stimulated primary human lymphocytes c
ultured in interleukin-2 were TK-transduced by a retroviral vector car
rying both TK and neomycin-resistance genes. After selection in G418,
more than 90% of the cells contained the TK gene as shown by a semiqua
ntitative polymerase chain reaction. In addition, 1 to 5 days of GCV e
xposure, at clinically achievable concentrations of 20 to 50 mu mol/L,
induced greater than or equal to 90% killing of G418-selected cells w
ithout affecting nontransduced cells. Correlation of the extent of T-c
ell kill and the proportion of TK-gene-transduced cells is consistent
with the absence of a bystander effect. Transduced cells were CD3(+) a
nd either CD8(+) or CD4(+) and retained functional properties of untra
nsduced cells. In vivo administration of GCV prevented tumor developme
nt after subcutaneous injection of TK-transduced murine myeloma cells
(MOPC-11), whereas such an effect was not observed on injection of unt
ransduced cells into the opposite flank. Our studies provide critical
information that (1) adequate numbers of TK-transduced lymphocytes can
be selected efficiently with greater than or equal to 90% purity, (2)
selected cells remain functional, (3) 24 hours of exposure to GCV at
clinically achievable concentration effects greater than or equal to 9
0% killing of selected cells, and (4) GCV is effective in vivo in kill
ing TK-transduced cells. Based on these data, a clinical study has bee
n initiated in patients with multiple myeloma with persistent or relap
sing disease after T-cell-depleted allogeneic transplants. (C) 1997 by
The American Society of Hematology.